Intracoronary injection of integrili

Phase 3

• Conditions: STEMI ??.; Angioplasty status; Z98.6

• Registration Number: IRCT20140512017666N3
• Lead Sponsor: Tabriz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 17 December 2019

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

TIMI FLOW equals zero
Acute Ant MI patient admitted to civil hospital emergency room under 12 hours
Ages over 16 years

Exclusion Criteria

Patients with coronary bypass candidiasis
Patients resuscitated with cardiogenic shock

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Cardiac enzyme levelsCardiac enzyme levels. Timepoint: It is measured 6 times at 4 hour intervals. Method of measurement: PPCI?.;Mortality. Timepoint: 1, 6 and 12 months after discharge. Method of measurement: Questionaire.;STEMI with primary angioplasty. Timepoint: Hospitalization Period. Method of measurement: ECG and enzyme.;In-hospital bleeding. Timepoint: Hospitalization Period. Method of measurement: Clinical examination and laboratory findings.;Heart failure. Timepoint: 1, 6 and 12 months after discharge. Method of measurement: Eco cardiography.